1. Home
  2. XPEL vs AORT Comparison

XPEL vs AORT Comparison

Compare XPEL & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XPEL Inc.

XPEL

XPEL Inc.

HOLD

Current Price

$45.16

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$23.09

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPEL
AORT
Founded
1999
1984
Country
United States
United States
Employees
1337
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
XPEL
AORT
Price
$45.16
$23.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$56.00
$49.40
AVG Volume (30 Days)
150.7K
546.9K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
12.12
165.62
EPS
1.03
N/A
Revenue
$476,200,000.00
$298,836,000.00
Revenue This Year
$12.64
$14.20
Revenue Next Year
$11.98
$11.20
P/E Ratio
$44.94
N/A
Revenue Growth
13.27
18.01
52 Week Low
$31.50
$19.16
52 Week High
$55.91
$48.25

Technical Indicators

Market Signals
Indicator
XPEL
AORT
Relative Strength Index (RSI) 42.09 N/A
Support Level $45.60 N/A
Resistance Level $46.71 N/A
Average True Range (ATR) 1.35 0.00
MACD -0.39 0.00
Stochastic Oscillator 23.02 0.00

Price Performance

Historical Comparison
XPEL
AORT

About XPEL XPEL Inc.

XPEL Inc is a supplier of protective films, coatings, and related services principally to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from Product, which includes Paint protection film and Window film. The company derives revenue from Service, which includes Software, Cutbank credits, and Installation labor. The majority of revenue is derived from the United States.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: